Clinical Trials on Secondary Hyperlipidemia in Australia
Total 141 results
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
University of South AustraliaAmerican Egg BoardCompletedHypercholesterolemia | Hyperlipidemias | Diet, Healthy | Physical InactivityAustralia
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Spain, Finland, Sweden, Canada
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Belgium, Germany, Hong Kong, Netherlands, France, Australia, Canada, South Africa, United Kingdom, Spain, Poland, Switzerland
-
AmgenCompletedHyperlipidemiaCanada, Denmark, France, United States, Czechia, New Zealand, Australia, South Africa, Italy, United Kingdom, Netherlands, Germany, Norway
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Australia, Belgium, Canada
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, France, Italy, Czechia, Taiwan, Switzerland, Korea, Republic of, Germany, Hong Kong, Netherlands, Australia, Belgium, Canada, Hungary, South Africa, Russian Federation, Spain, United Kingdom, Sweden, Mexico
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
AmgenCompletedHypercholesterolaemiaAustria, Italy, Belgium, Czechia, Switzerland, Spain, Slovakia, Germany, Portugal, Greece, Bulgaria, Sweden
-
AstraZenecaCompleted
-
Kirby InstituteNational Heart, Lung, and Blood Institute (NHLBI); The University of New South... and other collaboratorsCompletedHIV Infections | Cardiovascular Disease | Lipodystrophy | Glucose Metabolism | Lipid Metabolism | Metabolic AbnormalityAustralia
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRLCompletedInvestigating Effects of a Novel Nutraceutical on Hypercholesterolaemia in Australian Adults (CLoNE)HypercholesterolemiaAustralia
-
HighTide Biopharma Pty LtdCompletedHypercholesterolemiaAustralia
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaBrazil, Turkey, Taiwan, Argentina, India, Philippines, Singapore, Thailand, Australia, Chile, South Africa, Jordan, Korea, Republic of, Lebanon, United Arab Emirates, Malaysia, Peru, Israel, Indonesia, Guatemala, Hong Kong, Kuwait, ... and more
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
University of AdelaideUniversity of South AustraliaUnknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | HyperlipidemiaGreece, Austria, Finland, Italy, Hungary, Belgium, Spain, Ireland, Portugal, Slovenia, Switzerland
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
PfizerCompletedHyperlipidemia | Hypercholesterolemia, FamilialAustralia, Canada, United States, France, South Africa, Sweden, Norway, Denmark, Iceland
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Marea TherapeuticsRecruiting
-
Medical University of GrazActive, not recruitingSecondary Sclerosing CholangitisAustria
-
AmgenCompletedHyperlipidemiaCanada, France, Netherlands, United Kingdom, New Zealand, South Africa, Spain, United States, Australia, Germany, Sweden, Hong Kong, Switzerland, Norway
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
The George InstitutePfizer; Royal Prince Alfred Hospital, Sydney, Australia; Lipid and Cardiovascular... and other collaboratorsCompletedHypercholesterolemiaAustralia
-
Medical University of GrazRecruitingSecondary Sclerosis Cholangitis in Critically Ill PatientsAustria
-
Ludwig Boltzmann Institute for Digital Health and...REHA Zentrum Salzburg; Reha-Klinik MontafonRecruitingCardiovascular Diseases | Cardiac Rehabilitation | Secondary PreventionAustria
-
AstraZenecaCompletedDiabetes Mellitus | Peripheral Vascular Diseases | Atherosclerosis | Carotid Stenosis | Hyperlipidemias | Coronary Heart DiseaseAustria
-
The University of Western AustraliaNational Health and Medical Research Council, AustraliaUnknownFamilial Hypercholesterolaemia | HypertriglyceridaemiaAustralia
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Affiris AGMedical University of ViennaCompleted
-
Medical University of GrazCompletedFluvastatin 80 mg Ret. vs Combination With Ezetimibe 10 mg in Patients With High Cardiovascular RiskHypercholesterolemiaAustria
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
AstraZenecaCompletedDiabetes Mellitus | Peripheral Vascular Diseases | Atherosclerosis | Carotid Stenosis | Hyperlipidemias | Coronary Heart DiseaseAustria
-
Monash UniversityNational Health and Medical Research Council, AustraliaActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy AgeingAustralia
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
Rainer OberbauerAmgenCompletedSecondary Hyperparathyroidism | Left Ventricular Hypertrophy | Chronic Kidney Disease Requiring Chronic DialysisAustria
-
Medical University of GrazCompleted
-
Mylan Inc.Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.CompletedHypercholesterolemiaGermany, Austria
-
Unilever R&DCommonwealth Scientific and Industrial Research Organisation, AustraliaCompletedVascular Diseases | Diabetes Mellitus | HypercholesterolemiaAustralia
-
Novartis PharmaceuticalsCompletedSubfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMDAustralia